期刊文献+

丹莪妇康煎膏治疗子宫内膜性疾病及原发痛经的临床研究

The Clinical Analysis of Dan’e fukang jiangao in the the treatment of endometriosis and primarily algomenorrhea
下载PDF
导出
摘要 目的观察丹莪妇康煎膏治疗子宫内膜异位性疾病及原发痛经的临床疗效.方法:应用中药制剂丹莪妇康煎膏治疗子宫内膜异位性疾病患者200例及原发痛经患者100例,与孕三烯酮治疗子宫内膜异位性疾病患者及解热镇痛药治疗原发痛经患者各60例作对照 ,连续用药6个月,经周期判定总体症状改善、疗效、药物安全性的差异.结果:实验组总有效率88.7%;对照组采用孕三烯酮治疗60例子宫内膜异位性疾病及解热镇痛药治疗60例原发痛经, 其总有效率分别为81.3%、91.7%,用药后两组的痛经症状均明显平稳,差异无显著性(P〉0.05),但在症状改善上,治疗组优于对照组, 安全性明显高于对照组(P〈0.05).结论:丹莪妇康煎膏是治疗子宫内膜异位性疾病及原发痛经的一种既安全又有效的纯中药制剂,其疗效确切,特别对子宫内膜异位症的早期治疗及预防独具特色,值得进一步研究及推广应用. ObjectiveTo explore the clinical effect of Dan’e fukang jiangao in the the treatment of endometriosis and primarily algomenorrhea .Method:A total of 420 patients with endometriosis endometriosis and primarily algomenorrhea were divided into control group(120 cases) and experiment one(300 cases).The control group was treated by gestrinone and antipyretic analgesic, while the experimental group was treated by Dan’ e fukang jiangao.The clinical efficacy after six menstrual cycles were observed and compared. Results:There were no significantly statistical differences between the effects of the two groups after treatment(P〉0.05), but there were conspicuously statistical differences in pain relief and the safety between the two groups (P〈0.05). The amelioration of pain and the safe in the experimental group was obviously better than that in the control one. Conclusion:Dan'e fukang jiangao is a safe and effectual 、pure Chinese drugs pharmaceutics , the clinical effect of it in the the treatment of endometriosis and primarily algomenorrhea is certain.
出处 《世界中医药》 CAS 2015年第A02期929-930,共2页 World Chinese Medicine
关键词 子宫内膜异位性疾病 丹莪妇康煎膏 原发痛经 疗效 adenomyosis disease Dan’e fukang jiangao primarily algomenorrhea Clinical effect
  • 相关文献

参考文献3

二级参考文献11

共引文献41

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部